FDA Documents of GlaxoSmithKline Manufacturing S.p.A.

GlaxoSmithKline Manufacturing S.p.A. is an organization that has been audited by the FDA 22 times between 2003 and 2023 across all 6 sites.

Documents

FDA 483 GlaxoSmithKline Manufacturing S.p.A., Torrile | 2021

Out-of-stock
Issued on: Nov 12, 2021
Human Drug Form 483

FDA 483 GlaxoSmithKline Manufacturing S.p.A., Verona | 2018

Out-of-stock
Issued on: Jun 19, 2018
Human Drug Form 483

FDA 483 GlaxoSmithKline Manufacturing S.p.A., Verona | 2016

Out-of-stock
Issued on: May 20, 2016
Human Drug Form 483

FDA 483 GlaxoSmithKline Manufacturing S.p.A., Torrile | 2015

Out-of-stock
Issued on: May 27, 2015
Human Drug Form 483

FDA 483 GlaxoSmithKline Manufacturing S.p.A., Verona | 2014

Out-of-stock
Issued on: Mar 18, 2014
Human Drug Form 483

FDA 483 GlaxoSmithKline Manufacturing S.p.A., San Polo di Torrile | 2008

Out-of-stock
Issued on: Jul 31, 2008
Biologic Form 483

FDA 483 GlaxoSmithKline Manufacturing S.p.A., San Polo di Torrile | 2008

Out-of-stock
Issued on: Jun 30, 2008
Human Drug Form 483

FDA 483 GlaxoSmithKline Manufacturing S.p.A., Verona | 2008

Out-of-stock
Issued on: Jan 21, 2008
Human Drug Form 483

FDA 483 GlaxoSmithKline Manufacturing S.p.A., San Polo di Torrile | 2007

Out-of-stock
Issued on: Apr 20, 2007
Human Drug Form 483

FDA 483 GlaxoSmithKline Manufacturing S.p.A., San Polo di Torrile | 2003

Out-of-stock
Issued on: May 27, 2003
Biologic Form 483